{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:58:17Z","timestamp":1770814697819,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T00:00:00Z","timestamp":1338422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s12031-012-9815-4","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T10:07:50Z","timestamp":1338372470000},"page":"667-673","source":"Crossref","is-referenced-by-count":37,"title":["PACAP Immunoreactivity in Human Malignant Tumor Samples and Cardiac Diseases"],"prefix":"10.1007","volume":"48","author":[{"given":"Z.","family":"Szanto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs.","family":"Sarszegi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Reglodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Szabadfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Banki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Csanaky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Gaszner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Pinter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs.","family":"Szalai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,31]]},"reference":[{"key":"9815_CR1","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1749-6632.2010.05512.x","volume":"1200","author":"T Atlasz","year":"2010","unstructured":"Atlasz T, Szabadfi K, Kiss P et al (2010) Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects. Ann N Y Acad Sci 1200:128\u2013139","journal-title":"Ann N Y Acad Sci"},{"key":"9815_CR2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-08-0911","volume":"160","author":"R Borzsei","year":"2009","unstructured":"Borzsei R, Mark L, Tamas A et al (2009) Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk. Eur J Endocrinol 160:561\u2013565","journal-title":"Eur J Endocrinol"},{"key":"9815_CR3","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.peptides.2007.04.013","volume":"28","author":"B Botia","year":"2007","unstructured":"Botia B, Basille M, Allais A et al (2007) Neurotrophic effects of PACAP in the cerebellar cortex. Peptides 28:1746\u20131752","journal-title":"Peptides"},{"key":"9815_CR4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2174\/138161211795589337","volume":"17","author":"S Bourgault","year":"2011","unstructured":"Bourgault S, Chatenet D, Wurtz O et al (2011) Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug. Curr Pharm Des 17:1002\u201310024","journal-title":"Curr Pharm Des"},{"key":"9815_CR5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12031-010-9374-5","volume":"42","author":"R Brubel","year":"2010","unstructured":"Brubel R, Boronkai A, Reglodi D et al (2010) Changes in the expression of pituitary adenylate cyclase-activating polypeptide in the human placenta during pregnancy and its effects on the survival of JAR choriocarcinoma cells. J Mol Neurosci 42:450\u2013458","journal-title":"J Mol Neurosci"},{"key":"9815_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jms.1884","volume":"46","author":"R Brubel","year":"2011","unstructured":"Brubel R, Reglodi D, Jambor E et al (2011) Investigation of pituitary adenylate cyclase activating polypeptide in human gynecological and other biological fluids by using MALDI TOF mass spectrometry. J Mass Spectrom 46:189\u2013194","journal-title":"J Mass Spectrom"},{"issue":"1 Pt 1","key":"9815_CR7","first-page":"L42","volume":"277","author":"R Busto","year":"1999","unstructured":"Busto R, Carrero I, Guijarro LG et al (1999) Expression, pharmacological, and functional evidence for PACAP\/VIP receptors in human lung. Am J Physiol 277(1 Pt 1):L42\u2013L48","journal-title":"Am J Physiol"},{"key":"9815_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0196-9781(99)00202-8","volume":"21","author":"R Busto","year":"2000","unstructured":"Busto R, Prieto JC, Bodega G, Zapatero J, Carrero I (2000) Immunohistochemical localization and distribution of VIP\/PACAP receptors in human lung. Peptides 21:265\u2013269","journal-title":"Peptides"},{"key":"9815_CR9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0196-9781(03)00058-5","volume":"24","author":"R Busto","year":"2003","unstructured":"Busto R, Prieto JC, Bodega G, Zapatero J, Fogue L, Carrero I (2003) VIP and PACAP receptors coupled to adenylyl cyclase in human lung cancer: a study in biopsy specimens. Peptides 24:429\u2013436","journal-title":"Peptides"},{"key":"9815_CR10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1096-9861(20000717)423:1<26::AID-CNE3>3.0.CO;2-C","volume":"423","author":"MA Calupca","year":"2000","unstructured":"Calupca MA, Vizzard MA, Parsons RL (2000) Origin of pituitary adenylate cyclase-activating polypeptide (PACAP)-immunoreactive fibers innervating guinea pig parasympathetic cardiac ganglia. J Comp Neurol 423:26\u201339","journal-title":"J Comp Neurol"},{"key":"9815_CR11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.regpep.2005.02.012","volume":"129","author":"Y Chang","year":"2005","unstructured":"Chang Y, Lawson LJ, Hancock JC, Hoover DB (2005) Pituitary adenylate cyclase-activating polypeptide: localization and differential influence on isolated hearts from rats and guinea pigs. Regul Pept 129:139\u2013146","journal-title":"Regul Pept"},{"key":"9815_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(02)00445-7","volume":"328","author":"WI DeHaven","year":"2002","unstructured":"DeHaven WI, Cuevas J (2002) Heterogeneity of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide receptors in rat intrinsic cardiac neurons. Neurosci Lett 328:45\u201349","journal-title":"Neurosci Lett"},{"key":"9815_CR13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12031-008-9087-1","volume":"36","author":"A Dejda","year":"2008","unstructured":"Dejda A, Jolivel V, Bourgault S et al (2008) Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. J Mol Neurosci 36:26\u201337","journal-title":"J Mol Neurosci"},{"key":"9815_CR14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4049\/jimmunol.166.2.1028","volume":"166","author":"M Delgado","year":"2001","unstructured":"Delgado M, Ganea D (2001) Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-\u03baB, NF-AT, and early growth factors 2\/3. J Immunol 166:1028\u20131040","journal-title":"J Immunol"},{"key":"9815_CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0024-3205(96)00299-8","volume":"59","author":"M Draoui","year":"1996","unstructured":"Draoui M, Hida T, Jakowlew S, Birrer M, Zia F, Moody TW (1996) PACAP stimulates c-fos mRNAs in small cell lung cancer cells. Life Sci 59:307\u2013313","journal-title":"Life Sci"},{"key":"9815_CR16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1358\/dnp.2005.18.6.927930","volume":"18","author":"MC Dvorakova","year":"2005","unstructured":"Dvorakova MC (2005) Cardioprotective role of the VIP signaling system. Drug News Perspect 18:387\u2013391","journal-title":"Drug News Perspect"},{"key":"9815_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1196\/annals.1317.029","volume":"1070","author":"B Gasz","year":"2006","unstructured":"Gasz B, Racz B, Roth E et al (2006a) PACAP inhibits oxidative stress-induced activation of MAP kinase dependent apoptotic pathway in cultured cardiomyocytes. Ann N Y Acad Sci 1070:293\u2013297","journal-title":"Ann N Y Acad Sci"},{"key":"9815_CR18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.peptides.2005.06.022","volume":"27","author":"B Gasz","year":"2006","unstructured":"Gasz B, Racz B, Roth E et al (2006b) Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis. Peptides 27:87\u201394","journal-title":"Peptides"},{"key":"9815_CR19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2478\/v10042-010-0052-9","volume":"48","author":"J Godlewski","year":"2010","unstructured":"Godlewski J, Lakomy IM (2010) Changes in vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide and neuropeptide Y-ergic structures of the enteric nervous system in the carcinoma of the human large intestine. Folia Histochem Cytobiol 48:208\u2013216","journal-title":"Folia Histochem Cytobiol"},{"key":"9815_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s004410050980","volume":"291","author":"J Hannibal","year":"1998","unstructured":"Hannibal J, Ekblad E, Mulder H, Sundler F, Fahrenkrug J (1998) Pituitary adenylate cyclase activating polypeptide (PACAP) in the gastrointestinal tract of the rat: distribution and effects of capsaicin or denervation. Cell Tissue Res 291:65\u201379","journal-title":"Cell Tissue Res"},{"key":"9815_CR21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1196\/annals.1317.036","volume":"1070","author":"JC Hardwick","year":"2006","unstructured":"Hardwick JC, Tompkins JD, Locknar SA, Merriam LA, Young BA, Parsons RL (2006) Calcium influx through channels other than voltage-dependent calcium channels is critical to the pituitary adenylate cyclase-activating polypeptide-induced increase in excitability in guinea pig cardiac neurons. Ann N Y Acad Sci 1070:317\u2013321","journal-title":"Ann N Y Acad Sci"},{"key":"9815_CR22","doi-asserted-by":"crossref","first-page":"H1667","DOI":"10.1152\/ajpheart.2001.281.4.H1667","volume":"281","author":"M Hirose","year":"2001","unstructured":"Hirose M, Leatmanoratn Z, Laurita KR, Carlson MD (2001) Effects of pituitary adenylate cyclase-activating polypeptide on canine atrial electrophysiology. Am J Physiol Heart Circ Physiol 281:H1667\u2013H1674","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9815_CR23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jbbm.2004.03.002","volume":"61","author":"B Jakab","year":"2004","unstructured":"Jakab B, Reglodi D, Jozsa R et al (2004) Distribution of PACAP-38 in the central nervous system of various species determined by a novel radioimmunoassay. J Biochem Biophys Methods 61:189\u2013198","journal-title":"J Biochem Biophys Methods"},{"key":"9815_CR24","doi-asserted-by":"crossref","unstructured":"Koppan M, Varnagy A, Reglodi D et al (2012) Correlation between oocyte number and follicular fluid concentration of pituitary adenylate cyclase-activating polypeptide (PACAP) in women after superovulation treatment. J Mol Neurosci (in press) doi: 10.1007\/s12031-012-9743-3","DOI":"10.1007\/s12031-012-9743-3"},{"key":"9815_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-0115(99)00024-5","volume":"84","author":"JM Lauff","year":"1999","unstructured":"Lauff JM, Modlin IM, Tang LH (1999) Biological relevance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the gastrointestinal tract. Regul Pept 84:1\u201312","journal-title":"Regul Pept"},{"key":"9815_CR26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0167-0115(02)00194-5","volume":"109","author":"SV Le","year":"2002","unstructured":"Le SV, Yamaguchi DJ, McArdle CA, Tachiki K, Pisegna JR, Germano P (2002) PAC1 and PACAP expression, signaling, and effect on the growth of HCT8, human colonic tumor cells. Regul Pept 109:115\u2013125","journal-title":"Regul Pept"},{"key":"9815_CR27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0167-0115(02)00195-7","volume":"109","author":"A Levy","year":"2002","unstructured":"Levy A, Gal R, Granoth R, Dreznik Z, Fridkin M, Gozes I (2002) In vitro and in vivo treatment of colon cancer by VIP antagonists. Regul Pept 109:127\u2013133","journal-title":"Regul Pept"},{"key":"9815_CR28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000236498","volume":"101","author":"A Luts","year":"1993","unstructured":"Luts A, Uddman R, Alm P, Basterra J, Sundler F (1993) Peptide-containing nerve fibres in human airways: distribution and coexistence pattern. Int Arch Allergy Immunol 101:52\u201360","journal-title":"Int Arch Allergy Immunol"},{"key":"9815_CR29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-0115(02)00003-4","volume":"105","author":"M Miampamba","year":"2002","unstructured":"Miampamba M, Germano PM, Arli S et al (2002) Expression of pituitary adenylate cyclase-activating polypeptide and PACAP type 1 receptor in the rat gastric and colonic myenteric neurons. Regul Pept 105:145\u2013154","journal-title":"Regul Pept"},{"key":"9815_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0196-9781(93)90036-G","volume":"14","author":"TW Moody","year":"1993","unstructured":"Moody TW, Zia F, Makheja A (1993) Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells. Peptides 14:241\u2013246","journal-title":"Peptides"},{"key":"9815_CR31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1749-6632.2000.tb06947.x","volume":"921","author":"TW Moody","year":"2000","unstructured":"Moody TW, Walters J, Casibang M, Zia F, Gozes Y (2000) VPAC1 receptors and lung cancer. Ann N Y Acad Sci 921:26\u201332","journal-title":"Ann N Y Acad Sci"},{"key":"9815_CR32","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-0115(02)00196-9","volume":"109","author":"TW Moody","year":"2002","unstructured":"Moody TW, Leyton J, Casibang M, Pisegna J, Jensen RT (2002) PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells. Regul Pept 109:135\u2013140","journal-title":"Regul Pept"},{"key":"9815_CR33","doi-asserted-by":"crossref","unstructured":"Moody TW, Osefo N, Nuche-Berenguer B, Ridnour L, Wink D, Jensen RT (2012) Pituitary adenylate cyclase activating polypeptide causes tyrosine phosphorylation on the EGF receptor in lung cancer cells. J Pharmacol Exp Ther 341:873\u2013881","DOI":"10.1124\/jpet.111.190033"},{"key":"9815_CR34","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1253\/circj.CJ-09-1024","volume":"74","author":"H Mori","year":"2010","unstructured":"Mori H, Nakamachi T, Ohtaki H et al (2010) Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on doxorubicin-induced cardiomyopathy in mice. Circ J 74:1183\u20131190","journal-title":"Circ J"},{"key":"9815_CR35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0196-9781(93)90139-8","volume":"14","author":"S Naruse","year":"1993","unstructured":"Naruse S, Suzuki T, Ozaki T, Nokihara K (1993) Vasodilator effect of pituitary adenylate cyclase activating polypeptide (PACAP) on femoral blood flow in dogs. Peptides 14:505\u2013510","journal-title":"Peptides"},{"key":"9815_CR36","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/ijc.23308","volume":"122","author":"N Nemetz","year":"2008","unstructured":"Nemetz N, Abad C, Lawson G et al (2008) Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP. Int J Cancer 122:1803\u20131809","journal-title":"Int J Cancer"},{"key":"9815_CR37","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1161\/01.CIR.0000147235.53360.59","volume":"110","author":"C Otto","year":"2004","unstructured":"Otto C, Hein L, Brede M et al (2004) Pulmonary hypertension and right heart failure in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice. Circulation 110:3245\u20133251","journal-title":"Circulation"},{"key":"9815_CR38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1749-6632.2000.tb06967.x","volume":"921","author":"RL Parsons","year":"2000","unstructured":"Parsons RL, Rossignol TM, Calupca MA, Hardwick JC, Brass KM (2000) PACAP peptides modulate guinea pig cardiac neuron membrane excitability and neuropeptide expression. Ann N Y Acad Sci 921:202\u2013210","journal-title":"Ann N Y Acad Sci"},{"key":"9815_CR39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00318496","volume":"279","author":"AL Portbury","year":"1995","unstructured":"Portbury AL, McConalogue K, Furness JB, Young HM (1995) Distribution of pituitary adenylyl cyclase activating peptide (PACAP) immunoreactivity in neurons of the guinea-pig digestive tract and their projections in the ileum and colon. Cell Tissue Res 279:385\u2013392","journal-title":"Cell Tissue Res"},{"key":"9815_CR40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ygcen.2006.12.006","volume":"153","author":"B Racz","year":"2007","unstructured":"Racz B, Gasz B, Borsiczky B et al (2007) Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis. Gen Comp Endocrinol 153:115\u2013123","journal-title":"Gen Comp Endocrinol"},{"key":"9815_CR41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.regpep.2007.09.015","volume":"145","author":"B Racz","year":"2008","unstructured":"Racz B, Gasz B, Gallyas F Jr et al (2008) PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia\/reperfusion-induced cardiomyocyte apoptosis. Regul Pept 145:105\u2013115","journal-title":"Regul Pept"},{"key":"9815_CR42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12031-010-9349-6","volume":"42","author":"B Racz","year":"2010","unstructured":"Racz B, Reglodi D, Horvath G et al (2010) Protective effect of PACAP against doxorubicin-induced cell death in cardiomyocyte culture. J Mol Neurosci 42:419\u2013427","journal-title":"J Mol Neurosci"},{"key":"9815_CR43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF03346621","volume":"33","author":"D Reglodi","year":"2010","unstructured":"Reglodi D, Gyarmati J, Ertl T et al (2010) Alterations of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in the human plasma during pregnancy and after birth. J Endocrinol Invest 33:443\u2013445","journal-title":"J Endocrinol Invest"},{"key":"9815_CR44","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2174\/138161211795589355","volume":"17","author":"D Reglodi","year":"2011","unstructured":"Reglodi D, Kiss P, Lubics A, Tamas A (2011) Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des 17:962\u2013972","journal-title":"Curr Pharm Des"},{"key":"9815_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb06946.x","volume":"921","author":"JC Reubi","year":"2000","unstructured":"Reubi JC (2000) In vitro evaluation of VIP\/PACAP receptors in healthy and diseased human tissues. Clinical implications. Ann N Y Acad Sci 921:1\u201325","journal-title":"Ann N Y Acad Sci"},{"key":"9815_CR46","first-page":"3105","volume":"60","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Laderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA (2000) Vasoactive intestinal peptide\/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res 60:3105\u20133112","journal-title":"Cancer Res"},{"key":"9815_CR47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1749-6632.2008.03635.x","volume":"1163","author":"E Roth","year":"2009","unstructured":"Roth E, Weber G, Kiss P et al (2009) Effects of PACAP and preconditioning against ischemia\/reperfusion-induced cardiomyocyte apoptosis in vitro. Ann N Y Acad Sci 1163:512\u2013516","journal-title":"Ann N Y Acad Sci"},{"key":"9815_CR48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-0115(02)00193-3","volume":"109","author":"H Sano","year":"2002","unstructured":"Sano H, Miyata A, Horio T, Nishikimi T, Matsuo H, Kangawa K (2002) The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor. Regul Pept 109:107\u2013113","journal-title":"Regul Pept"},{"key":"9815_CR49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0006-8993(00)02885-7","volume":"882","author":"LK Schoenfeld","year":"2000","unstructured":"Schoenfeld LK, Souder JA, Hardwick JC (2000) Pituitary adenylate cyclase-activating polypeptide innervation of the mudpuppy cardiac ganglion. Brain Res 882:180\u2013190","journal-title":"Brain Res"},{"key":"9815_CR50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/138161211795049679","volume":"17","author":"T Seaborn","year":"2011","unstructured":"Seaborn T, Masmoudi-Kouli O, Fournier A, Vaudry H, Vaudry D (2011) Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. Curr Pharm Des 17:204\u2013214","journal-title":"Curr Pharm Des"},{"key":"9815_CR51","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2174\/1381612043383548","volume":"10","author":"A Somogyvari-Vigh","year":"2004","unstructured":"Somogyvari-Vigh A, Reglodi D (2004) Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr Pharm Des 10:2861\u20132889","journal-title":"Curr Pharm Des"},{"key":"9815_CR52","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0306-4522(92)90064-9","volume":"46","author":"F Sundler","year":"1992","unstructured":"Sundler F, Ekblad E, Absood A, Hakanson R, Koves K, Arimura A (1992) Pituitary adenylate cyclase activating peptide: a novel vasoactive intestinal peptide-like neuropeptide in the gut. Neuroscience 46:439\u2013454","journal-title":"Neuroscience"},{"key":"9815_CR53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12031-008-9064-8","volume":"36","author":"P Szakaly","year":"2008","unstructured":"Szakaly P, Kiss P, Lubics A et al (2008) Effects of PACAP on survival and renal morphology in rats subjected to renal ischemia\u2013reperfusion. J Mol Neurosci 36:89\u201396","journal-title":"J Mol Neurosci"},{"key":"9815_CR54","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1196\/annals.1317.086","volume":"1070","author":"M Ushiyama","year":"2006","unstructured":"Ushiyama M, Sugawara H, Inoue K, Kangawa K, Yamada K, Miyata A (2006) Characterization of the PAC1 variants expressed in the mouse heart. Ann N Y Acad Sci 1070:586\u2013590","journal-title":"Ann N Y Acad Sci"},{"key":"9815_CR55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D, Falluel-Morel A, Bourgault S et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20\u00a0years after the discovery. Pharmacol Rev 61:283\u2013357","journal-title":"Pharmacol Rev"},{"key":"9815_CR56","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1749-6632.1996.tb17531.x","volume":"805","author":"Y Wei","year":"1996","unstructured":"Wei Y, Mojsov S (1996) Multiple human receptors for pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide are expressed in a tissue-specific manner. Ann N Y Acad Sci 805:624\u2013627","journal-title":"Ann N Y Acad Sci"},{"key":"9815_CR57","first-page":"4886","volume":"55","author":"F Zia","year":"1995","unstructured":"Zia F, Fagarasan M, Bitar K et al (1995) Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells. Cancer Res 55:4886\u20134891","journal-title":"Cancer Res"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-012-9815-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-012-9815-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-012-9815-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:24:50Z","timestamp":1559427890000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-012-9815-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,31]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["9815"],"URL":"https:\/\/doi.org\/10.1007\/s12031-012-9815-4","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,31]]}}}